Heparin plus aspirin for unstable angina

Area of Science:

• Cardiology
• Pharmacology

Background:

• Unstable angina is a critical condition requiring prompt and effective treatment.
• Current treatment guidelines often involve antiplatelet therapy, but the role of anticoagulants is still debated.

Purpose of the Study:

• To evaluate the efficacy and safety of combining heparin with aspirin for treating unstable angina.
• To determine the impact on myocardial infarction, death, and other adverse events.

Main Methods:

• A meta-analysis was conducted, synthesizing data from six randomized controlled trials.
• Trials compared aspirin monotherapy against aspirin plus heparin combination therapy.

Main Results:

• The combination of aspirin and heparin reduced the risk of myocardial infarction or death during treatment (Relative Risk: 0.67).
• A significant reduction was also observed in recurrent ischemic pain (RR: 0.68).
• Increased risk for major bleeding events was noted (RR: 1.99).

Conclusions:

• Combining heparin with aspirin is effective in reducing short-term risks of myocardial infarction and death in unstable angina.
• The benefits must be weighed against an increased risk of major bleeding.